A clinical study to evaluate the effect of Naagaraadi Vati in the management of Non Alcoholic Fatty Liver Disease

A Randomized Controlled Clinical Trial to evaluate the effect of Naagaraadi Vati in the management of Non Alcoholic Fatty Liver Disease - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/102958

Enrollment

Registered

2026-02-04

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 18-70 years Patients having Grade I and Grade II fatty liver in USG. Patient willing to participate in trial.

Exclusion criteria

Exclusion criteria: History of Alcohol Intake (consuming less than 30 g (three units) of alcohol per day for men and less than 20 g (two units) of alcohol per day for women). History of all types of Jaundice, Hepatitis, Liver Cirrhosis. Patient under Insulin Therapy Known case of Malignancy and TB Pregnant and Lactating Women

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of Naagaraadi Vati on fatty liver changes in USG Findings. Timepoint: 61 day	—

Secondary

Measure	Time frame
To evaluate the effect of Naagaraadi Vati on LFT and symptoms of Non Alcoholic Fatty Liver Disease and To compare the effect of Naagaraadi Vati and Rohitakadi Vati in the management of Non Alcoholic Fatty Liver Disease.Timepoint: 61 day	—

Countries

India

Contacts

Public ContactDr Teesha Sharma

Sri Jayendra Saraswathi Ayurveda College and Hospital

drroutkc@sjsach.org.in9444881980

Outcome results